• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PAX Health Acquires Neuropsychology and Counseling Associates, Expanding Comprehensive Mental Health Services Across New Jersey

    9/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email

    RED BANK, N.J., Sept. 23, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Neuropsychology and Counseling Associates, a comprehensive outpatient mental health practice serving children, adolescents, adults, and families throughout New Jersey.

    Brain tree logo (PRNewsfoto/PAX Health)

    This strategic acquisition enhances PAX Health's portfolio of specialized mental health services and expands its geographic footprint in New Jersey, strengthening the company's ability to deliver neuropsychological evaluations, cognitive training, and comprehensive behavioral healthcare across diverse patient populations.

    "Neuropsychology and Counseling Associates has established an outstanding reputation for providing specialized neuropsychological care and comprehensive mental health treatment," said Anthony DeSena, CEO of PAX Health. "Their team's expertise in clinical neuropsychology, memory support services, and evidence-based therapeutic approaches adds significant value to our service offerings and aligns perfectly with our mission to improve access to comprehensive behavioral healthcare, further supporting the expansion of our geographic footprint."

    Founded by Theodore J. Batlas, Psy.D., Neuropsychologist, former Chief of Psychology at Jersey Shore University Medical Center, Neuropsychology and Counseling Associates has over thirty years of experience providing comprehensive mental health services. The practice specializes in clinical neuropsychology, memory support services, dementia screening, cognitive training, forensic neuropsychology, rehabilitation, biofeedback, and marriage and family counseling. Their professional staff is licensed and certified in clinical neuropsychology, clinical psychology, rehabilitation, biofeedback, and marriage and family counseling.

    "We are truly excited about our partnership with PAX Health, as it will significantly enhance our ability to provide comprehensive neuropsychological services to a wider population," said Michael P. Heptig, Clinical Neuropsychologist, Co-Director and Partner at Neuropsychology and Counseling Associates. "Addressing the increasing demand for behavioral health services has been a considerable challenge in recent years. We are confident that this partnership will enable us to more effectively meet the needs of our community and further the PAX vision of providing personalized mental health treatment in a compassionate setting."

    This acquisition represents another significant step in PAX Health's growth strategy, supported by healthcare-focused private equity firm HCAP Partners and funds managed by global investment management firm Hamilton Lane. The integration will enhance PAX Health's ability to deliver customized behavioral health solutions while preserving Neuropsychology and Counseling Associates' established approach to specialized neuropsychological care.

    About PAX Health

    PAX Health is a leading behavioral health company dedicated to providing innovative and comprehensive solutions for mental health and well-being. Through strategic integration of best practices and resources, PAX Health delivers tailored solutions for individuals, businesses, and communities seeking comprehensive behavioral health services.

    About Neuropsychology and Counseling Associates

    Neuropsychology and Counseling Associates offers comprehensive outpatient mental health treatment for children, adolescents, adults, and families throughout New Jersey. With over thirty years of experience, the practice provides specialized services including clinical neuropsychology, memory support services, dementia screening, neuropsychological evaluations, cognitive training, biofeedback, rehabilitation, and marriage and family counseling. The practice serves patients through both in-person and telehealth services, delivering evidence-based treatment approaches including CBT, psychotherapy, and psychiatric medication management.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pax-health-acquires-neuropsychology-and-counseling-associates-expanding-comprehensive-mental-health-services-across-new-jersey-302563249.html

    SOURCE PAX Health

    Get the next $HLNE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    12/11/2025$166.00Buy
    UBS
    11/6/2025$165.00Neutral → Buy
    Goldman
    10/14/2025$181.00Perform → Outperform
    Oppenheimer
    10/13/2025$150.00Mkt Perform → Outperform
    Keefe Bruyette
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    More analyst ratings

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    YCharts Introduces Hamilton Lane Benchmarks to Bring Private Markets Insights to Advisors

    New benchmarks from Hamilton Lane provide advisors with trusted data to evaluate private markets strategies and allocations. YCharts, a leading investment research and client engagement platform, today announced the introduction of benchmark data from leading global private markets investment firm Hamilton Lane (NASDAQ:HLNE). The addition brings new visibility into private markets, helping financial advisors benchmark private fund performance, evaluate portfolio diversification and explain the role of private markets in client strategies. With private markets playing an increasingly important role in client portfolios, advisors need a new set of tools to assess private investments with

    2/10/26 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Penn., Feb. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2025. The Company issued a full detailed presentation of its third quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on March 20, 2026 that will be paid on April 6, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    2/3/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Closes on Nearly $2 Billion in Infrastructure Opportunities Fund II and Related Vehicles, Tripling Size of Predecessor Fund

    IOF II closed on over $1.5 billion of capital commitments, with nearly $400 million of additional capital committed alongside the Fund in related vehicles, representing almost $2 billion in total commitmentsThe Fund and related vehicles are more than three times larger than predecessor vehicle and well exceeded its $1.25 billion targetCONSHOHOCKEN, Pa., Feb. 2, 2026 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the final closing of the Hamilton Lane Infrastructure Opportunities Fund II ("IOF II" or "the Fund"), with $1.5 billion closed in the Fund and another nearly $400 million invested alongside the Fund in related veh

    2/2/26 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Hamilton Lane with a new price target

    UBS resumed coverage of Hamilton Lane with a rating of Buy and set a new price target of $166.00

    12/11/25 9:09:19 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Goldman with a new price target

    Goldman upgraded Hamilton Lane from Neutral to Buy and set a new price target of $165.00

    11/6/25 8:41:24 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00

    10/14/25 8:37:36 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    SEC Filings

    View All

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    2/3/26 4:18:01 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    2/3/26 7:00:09 AM ET
    $HLNE
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    11/4/25 4:16:24 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan gifted 14,375 shares and received a gift of 14,375 shares, increasing direct ownership by 1% to 1,328,822 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    2/9/26 4:35:09 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    New insider Mcallister Margaret Anne claimed ownership of 59,006 shares and claimed ownership of 300,000 units of Class B Common Stock (SEC Form 3)

    3 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:03:07 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Hamilton Lane and Guardian Announce Long-Term Strategic Partnership

    CONSHOHOCKEN, Pa. and NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Leading private markets firm Hamilton Lane (NASDAQ:HLNE) and The Guardian Life Insurance Company of America® ("Guardian"), one of the nation's largest life insurers and a leading provider of employee benefits, today announced an innovative, long-term strategic partnership. Through this partnership, Hamilton Lane will manage Guardian's existing private equity portfolio of nearly $5 billion. Guardian will also commit to invest approximately $500 million per year in private equity for the next 10 years through Hamilton Lane. This commitment maintains Guardian's typical annual contribution to the asset class and supports its general a

    11/3/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Penn., Feb. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2025. The Company issued a full detailed presentation of its third quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on March 20, 2026 that will be paid on April 6, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    2/3/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Guardian unveils "The Year Ahead," revealing how 2026's major financial themes will shape Americans' financial future

    Inaugural report empowers individuals to navigate uncertainty, identify emerging opportunities, and plan holistically across their financial lives NEW YORK, Jan. 20, 2026 /PRNewswire/ -- As headlines and data often paint a conflicting economic picture, The Guardian Life Insurance Company of America® (Guardian) has issued Guardian Wealth Insights: The Year Ahead, an outlook designed to help Americans make sense of the financial opportunities and challenges in 2026. Read Guardian Wealth Insights: The Year Ahead here From navigating megatrends like inflation and regulatory change

    1/20/26 9:30:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Third Quarter Fiscal 2026 Results on February 3, 2026

    CONSHOHOCKEN, Pa., Jan. 13, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the third fiscal quarter ended December 31, 2025 before the market opens on Tuesday, February 3, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on February 3 to discuss the results for the third fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by  clicking here (https://shareholders.hamiltonlane.com/) at least

    1/13/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance